A short review of cognitive and functional neuroimaging studies of cholinergic drugs: Implications for therapeutic potentials

Journal of Neural Transmission

Volumn 109, Issue 5-6, 2002, Pages 857-870

  Freo, U ^a   Pizzolato, G ^a   Dam, M ^a   Ori, C ^a   Battistin, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cerebral blood flow; Cerebral glucose metabolism; Cholinergic; Dementia; Donepezil; PET; Rivastigmine; SPECT

Indexed keywords

ARECOLINE; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; HEPTYLSTIGMINE TARTRATE; LEVACECARNINE; MECAMYLAMINE; OXOTREMORINE; PHYSOSTIGMINE; RIVASTIGMINE; SCOPOLAMINE; TACRINE;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN REGION; COGNITION; COGNITIVE DEFECT; DOSE RESPONSE; DRUG EFFECT; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; IATROGENIC DISEASE; LEWY BODY; MEMORY; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOIDISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS; VISUAL SYSTEM;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; CHOLINERGIC AGENTS; COGNITION; HUMANS; MEMORY; MEMORY DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036323475     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020200070     Document Type: Article

References (81)

1. Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat
2. Metabolic response to tacrine (THA) and physostigmine in the aged rat brain
3. Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats
4. Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: Effects of acute administration of L-acetylcarnitine
5. Comparison of cholinergic drug effect on regional brain glucose consumption in rats and humans by means of autoradiography and positron emission tomography
6. Physostigmine results in an increased decrement in brain consumption in Alzheimer's disease
7. Effect of donepezil on cognition in thalamic dementia
8. SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroamino-acridine and lecithin
9. The metabolic pattern of young subjects given scopolamine
10. Glucose utilization in the Papez circuit: Effects of oxotremorine and scopolamine
11. Aging and cholinergic system: A 2-deoxyglucose study in the rat brain
12. Sustained cortical metabolic responsivity to physostigmine after nucleus basalis magnocellularis ablation in rats
13. Vascular dementia: A construct in evolution
14. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers
15. Role of prefrontal cortex and striatal output system in short term memory deficits associated with ageing, basal forebrain lesion and cholinergic-rich grafts
16. Functional MRI and its applications to the clinical neurosciences
17. Effect of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease
18. Cerebral metabolic effects of serotonin drugs and neurotoxins. A review article
19. Reversal by physostigmine of age-related changes in cerebral blood flow patterns during working memory
20. The cholinesterase inhibitor donepezil improves cognitive performance in vascular dementia
21. Effects of acetylcholinesterase inhibition in mild cognitive impairment (MCI): Preliminary results with rivastigmine
22. Cholinergic stimulation alters performance and task-specific regional cerebral bloodflow during working memory
23. Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: A positron emission tomography regional cerebral blood flow study in healthy humans
24. Cholinergic enhancement and selectivity of perceptual processing during working memory
25. Alzheimer's disease: Current and future therapeutic perspectives
26. Effect of central cholinergic stimulation on regional cerebral bloodflow in Alzheimer's disease
27. Muscarinic and nicotinic contributions to cognitive function and cortical blood flow
28. The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during performance of a memory task
29. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairment
30. Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement and EEG
31. Response to tacrine in patients with dementia of the Alzheimer's type: Cerebral perfusion change in mental status
32. Cholinergic influences on hippocampal glucose metabolism
33. Metabolic activation by a visual recognition task for assessment of therapeutic efficacy in Alzheimer's disease
34. Cerebral pharmacodynamic of physostigime in Alzheimer's disease investigated using single-photon computerised tomography
35. A case of Korsakoff's syndrome improved by high doses of donepezil
36. Donepezil for psychotropic-induced memory loss
37. Overlap between pathology of Alzheimer disease and vascular dementia
38. An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors
39. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy
40. Differentiation of vascular dementia from AD on neuropsychological tests
41. Open-label study of donepezil in traumatic brain injury
42. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study
43. Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease
44. Use of donepezil for vascular dementia: Preliminary clinical experience
45. Muscarinic versus nicotinic modulation of a visual task. A Pet study using drug probes
46. Oral tetrahydroaminoacridine treatment of Alzheimer disease evaluated clinically and by regional blood floow and EEG
47. A double FDG/PET study of the effect of scopolamine in older adults
48. Cerebral blood flow responses to somatosensory stimulation are unaffected by scopolamine in unanesthetized rat
49. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease
50. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography
51. Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats
52. Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocin-treated rats
53. Mild cognitive impairment. Clinical characterization and outcome
54. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: Implications regarding identification of brain structures involved in consolidation of memory traces
55. Positron emission tomography (PET) study of the acute cerebral effect of L-α-glyceyl-phosphoryl-etanolamine in mild Alzheimer's disease patients
56. Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease
57. Physostigmine reversal of scopolamine-induced hypofrontality
58. Acetylcholinesterase inhibition in dementia with Lewy bodies: Results of a prospective pilot trial
59. Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal and visuospatial funciton in dementia of the Alzheimer's type
60. Anatomical and functional brain imaging in Alzheimer disease
61. Cognitive effects of nicotine
62. Tetrahydroaminoacridine modulates technetium-99m-labelled ethylene dicysteinate retention in Alzheimer disease measured with single photon emission computed tomography imaging
63. A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: Functional MRI correlates
64. Regional brain activity during shape recognition impaired by scopolamine challange to encoding
65. Cholinergic cerebral vasodilatation in the rabbit: Absence of concomitant metabolic activation
66. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats
67. Donepezil-induced REM sleep augmentation enhances memory performace in elderly, healthy persons
68. Pharmacodynamic an early clinical studies with velnacrine
69. Human serial learning: Enhancement with arecoline and choline and impairment with scopolamine
70. 14C]deoxyglucose method for measurement of local cerebral glucose utilization: Theory, procedure and normal value in the conscious and anesthetized albino rat
71. Age-associated functional impairment of specific neurotransmitter systems: Detection by pharmacological brain metabolism studies and criteria for design of human investigations
72. Arecoline-induced elevations of regional cerebral metabolism in conscious rat
73. Regional cerebral metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged rats
74. Changes in rCBF images in patients with Alzheimer's disease receiving donepezil therapy
75. Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: A positron emission tomography study in unanesthetized monkeys
76. Physostigmine in Alzheimer's disease: Effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography
77. The acetylcholine releaser linorpidine increases parietal regional cerebral blood flow in Alzheimer's disease
78. Visual form of Alzheimer's disease and its response to anticholinesterase therapy
79. The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia
80. Adjunctive donepezil in attention deficit hyperactivity disorder: Case series
81. Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease